טוען...
Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition
Selenium supplement has been shown in clinical trials to reduce the risk of different cancers including lung carcinoma. Previous studies reported that the antiproliferative and pro-apoptotic activities of methylseleninic acid (MSA) in cancer cells could be mediated by inhibition of the PI3K pathway....
שמור ב:
| הוצא לאור ב: | Pharmacol Res |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4850087/ https://ncbi.nlm.nih.gov/pubmed/26375988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2015.09.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|